San Antonio, Texas USA (UroToday.com) Tracey Krupski, University of Virginia, discussed surveillance for kidney cancer. The current AUA guidelines apply risk stratification to renal masses with varying follow-up.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
These recommendations are not based on level one evidence. SEER-Medicare data among patients who underwent partial nephrectomy, approximately 15% of patients underwent guideline recommended surveillance following treatment with 33% having no abdominal imaging. Up to 40$ had more imaging than guideline recommendations. Using Monte Carlo modeling further refinement of imaging according to tumor size, costs and radiation exposure, however, there are inherent limitations of this type of modeling.
Presented By: Tracey Krupski, University of Virginia
Written By: Stephen B. Williams, MD and Ashish M. Kamat
17th Annual Meeting of the Society of Urologic Oncology - November 30 -December 2, 2016 – San Antonio, Texas USA